Heart Failure is a progressive condition, and medical management strategies for this patient population has evolved over the years. This program will introduce CCM® therapy, review the action mechanism, and how the treatment works at the myocardial level. The faculty will review the clinical safety data surrounding the therapy as well as the indications for use. Evaluation and screening of patients that continue to be symptomatic from their heart failure indications despite being on guideline-directed medical treatment continue to be a challenge on all levels. Our faculty will discuss screening best practices, from both an electrophysiology and heart failure perspective, and how to establish a baseline for patients while giving them access to CCM® therapy that they may qualify to undertake.